SCHEMBL25944401

SCHEMBL25944401

CC(C)(C)OC(=O)n1c(Cn2cccc(NC(=O)CCC/C=C/C(=O)N3CCCC3)c2=O)cc2cc(F)ccc21

nearest known ligand 0.74

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAP4K1 Q92918 20/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25944463 0.90 MAP4K1 (0.60) MAP4K1
SCHEMBL25944481 0.88 MAP4K1 (0.69) MAP4K1
SCHEMBL25945514 0.86 MAP4K1 (0.78) MAP4K1
SCHEMBL21703193 0.85 MAP4K1 (1.00) MAP4K1
SCHEMBL23453196 0.84 MAP4K1 (0.84) MAP4K1
SCHEMBL21702975 0.83 MAP4K1 (0.76) MAP4K1
SCHEMBL21703194 0.83 MAP4K1 (1.00) MAP4K1
SCHEMBL25946397 0.82 MAP4K1 (0.61) MAP4K1
SCHEMBL25941045 0.81 MAP4K1 (0.77) MAP4K1
SCHEMBL25947838 0.81 MAP4K1 (0.56) MAP4K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4219460-A1 TRANSGLUTAMINASE 2 (TG2) INHIBITORS Sitari Pharma, Inc. (US) 2023-08-02 EP disclosed